Unknown

Dataset Information

0

Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Lyski Z 

PROVIDER: S-EPMC8651482 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia.
| S-EPMC8632355 | biostudies-literature
Unknown Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia.
| S-EPMC8500836 | biostudies-literature
Unknown SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia.
| S-EPMC8693592 | biostudies-literature
Unknown Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
| S-EPMC8687760 | biostudies-literature
Unknown Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
| S-EPMC8519417 | biostudies-literature
Unknown Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.
| S-EPMC5356881 | biostudies-literature
Unknown Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.
| S-EPMC8789382 | biostudies-literature
Unknown Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19.
| S-EPMC8282116 | biostudies-literature
Unknown Cellular origin and pathophysiology of chronic lymphocytic leukemia.
| S-EPMC3501361 | biostudies-literature
Unknown Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
| S-EPMC8061088 | biostudies-literature